Abstract:Sphingolipids, sphingolipid metabolizing enzymes, and their receptors network are being recognized as part of the signaling mechanisms, which govern breast cancer cell growth, migration, and survival during chemotherapy treatment. Approximately 70% of breast cancers are estrogen receptor (ER) positive and, thus, rely on estrogen signaling. Estrogen activates an intracellular network composed of many cytoplasmic and nuclear mediators. Some estrogen effects can be mediated by sphingolipids. Estrogen activates sphingosine kinase 1 (SphK1) and amplifies the intracellular concentration of sphingosine-1-phosphate (S1P) in breast cancer cells during stimulation of proliferation and survival. Specifically, Estrogen activates S1P receptors (S1PR) and induces growth factor receptor transactivation. SphK, S1P, and S1PR expression are causally associated with endocrine resistance and progression to advanced tumor stages in ER-positive breast cancers in vivo. Recently, the network of SphK/S1PR was shown to promote the development of ER-negative cancers and breast cancer stem cells, as well as stimulating angiogenesis. Novel findings confirm and broaden our knowledge about the cross-talk between sphingolipids and estrogen network in normal and malignant cells. Current S1PRs therapeutic inhibition was indicated as a promising chemotherapy approach in non-responsive and advanced malignancies. Considering that sphingolipid signaling has a prominent role in terminally differentiated cells, the impact should be considered when designing specific SphK/S1PR inhibitors. This study analyzes the dynamic of the transformation of sphingolipid axis during a transition from normal to pathological condition on the level of the whole organism. The sphingolipid-based mediation and facilitation of global effects of estrogen were critically accented as a bridging mechanism that should be explored in cancer prevention.

Novel Effects Of Sphingosylphosphorylcholine On The Apoptosis Of Breast Cancer Via Autophagy/Akt/P38 And Jnk Signaling

Regulation Of Apoptosis And Autophagy By Sphingosylphosphorylcholine In Vascular Endothelial Cells

Inhibition of autophagy promoted sphingosylphosphorylcholine induced cell death in non-small cell lung cancer cells.

Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells

Cancer Therapy : Preclinical Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI 3 K / Akt / NFk B Pathway in Human Non – Small Cell Lung Cancer

Mass Spectrometry Detects Sphingolipid Metabolites for Discovery of New Strategy for Cancer Therapy from the Aspect of Programmed Cell Death

Data from Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-κB Pathway in Human Non–Small Cell Lung Cancer

SPC24 Regulates Breast Cancer Progression by PI3K/AKT Signaling

Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming

Sphk1 interference suppresses proliferation,apoptosis and migration in human MCF-7 breast cancer cells

The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy

Sphingosylphosphorylcholine Protects Cardiomyocytes Against Ischemic Apoptosis Via Lipid Raft/pten/akt1/mtor Mediated Autophagy

SPC24 Regulates breast cancer progression by PI3K/AKT signaling.

Sulfated Polysaccharide-Protein Complex Sensitizes Doxorubicin-Induced Apoptosis of Breast Cancer Cells in Vitro and in Vivo.

Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer

Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models

Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment

Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway.

Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer

Nanoparticle (Np)-Mediated APOC1 Silencing to Inhibit MAPK/ERK and NF-κB Pathway and Suppress Breast Cancer Growth and Metastasis.

Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF10A Cells via ERK2